Zdrowie i gospodarka · 28/09/2010

FDA Proposes Amendment to Special Controls for Herpes Simplex Virus Serological Assay Device

The US Food and Drug Administration (FDA) is proposing to update the special controls for devices that test for herpes simplex virus (HSV) antibodies in blood samples, a move that could impact companies manufacturing these devices, including those using the Abbott Laboratories (ABT) HSV serological assay device.